Open Access. Powered by Scholars. Published by Universities.®
Chemical and Pharmacologic Phenomena Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medical Pharmacology (2)
- Medical Specialties (2)
- Translational Medical Research (2)
- Behavioral Medicine (1)
- Chemicals and Drugs (1)
-
- Critical Care (1)
- Emergency Medicine (1)
- Hepatology (1)
- Medical Humanities (1)
- Mental and Social Health (1)
- Other Chemicals and Drugs (1)
- Other Medical Sciences (1)
- Pharmaceutical Preparations (1)
- Pharmacy Administration, Policy and Regulation (1)
- Pharmacy and Pharmaceutical Sciences (1)
- Primary Care (1)
- Substance Abuse and Addiction (1)
- Keyword
Articles 1 - 3 of 3
Full-Text Articles in Chemical and Pharmacologic Phenomena
Substance Abuse Relapse Is Not About Willpower But Is The Culmination Of Psychological And Socioeconomic Stress, Paul A. Steffes
Substance Abuse Relapse Is Not About Willpower But Is The Culmination Of Psychological And Socioeconomic Stress, Paul A. Steffes
Clinical Research in Practice: The Journal of Team Hippocrates
The author reflects on the impact of non-judgmental listening on patient care outcomes.
Andexanet Alfa Is An Effective Reversal Agent For Factor Xa Inhibitors In Patients That Develop Intracranial Hemorrhage, Joseph Friedli
Andexanet Alfa Is An Effective Reversal Agent For Factor Xa Inhibitors In Patients That Develop Intracranial Hemorrhage, Joseph Friedli
Clinical Research in Practice: The Journal of Team Hippocrates
A critical appraisal and clinical application of Connolly SJ, Milling TJ, Eikelboom JW, et al. Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. N Engl J Med. 2016;375(12):1131-1141. doi: 10.1056/NEJMoa1607887.
Icatibant Is Not Helpful For The Treatment Of Ace Inhibitor-Induced Angioedema, Samantha R. Schwartz
Icatibant Is Not Helpful For The Treatment Of Ace Inhibitor-Induced Angioedema, Samantha R. Schwartz
Clinical Research in Practice: The Journal of Team Hippocrates
A critical appraisal and clinical application of Sinert R, Levy P, Bernstein JA, et al. Randomized trial of icatibant for angiotensin-converting enzyme inhibitor-induced upper airway angioedema. J Allergy Clin Immunol Pract. 2017; 5(5): 1402-1409. doi: 10.1016/j.jaip.2017.03.003.